Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 10.99 Billion | USD 20.62 Billion | 7.24% | 2023 |
The global Substance Abuse Treatment market size was worth around USD 10.99 billion in 2023 and is predicted to grow to around USD 20.62 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.24% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Substance Abuse Treatment market on a global and regional level.
People are abusing substances like alcohol, tobacco, and other drugs for a variety of complicated reasons, but it is clear that society is paying a significant cost. The Substance Abuse and Mental Health Services Administration (SAMHSA) estimated in 2015 that nearly 22 million people at least 12 years of age needed treatment for substance abuse. Drug abuse treatment plans not only help addicts detoxify in a safe environment but also help them through all stages of the recovery process. In the management of drug abuse and addiction issues, different treatment methodologies are used.
The study includes drivers and restraints for the Substance Abuse Treatment market along with the impact they have on the demand over the forecast period.
Additionally, the report includes the study of opportunities available in the Substance Abuse Treatment market on a global level. In order to give the users of this report a comprehensive view of the Substance Abuse Treatment market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market.
The study encompasses a market attractiveness analysis, wherein Abuse Type, Treatment Type, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.Request Free Sample
Factors such as increased awareness of patients, higher rate of seeking treatment, increased government intervention, and encouragement to curb substance abuse in all countries are driving the growth of the global market for substance abuse treatment. It is observed that the market for nicotine addiction treatment held the largest market share because the increased number of addicted tobacco populations, the increased number of approved medicines, and the increased use of nicotine with other stimulants affect the growth of the global market for nicotine addiction treatment.
Drug awareness initiatives, as well as associated prevention programs, include a rise in patient awareness, an increase in the rate of treatment-seeking driven by increases in government intervention, and an increased focus on curbing misuse of drugs in many countries. Successful treatment for substance abuse has been growing with new drugs that avoid relapse and regulate drug cravings as well. Such factors may play a role in the future growth of the sector.
The study provides a decisive view of the Substance Abuse Treatment market by segmenting the market based on Abuse Type, Treatment Type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
Based on Abuse Type, the market is segmented into Alcohol Dependence, Tobacco/Nicotine addiction, Drug abuse, and others. It is expected that the drug abuse segment accounts for the maximum share of the Substance Abuse Treatment market owing to the increasing addiction to opioids.
Based on Treatment Type, the market is segmented into Alcohol addiction treatment, Tobacco/Nicotine addiction treatment, Drug abuse treatment, and Others. The alcohol addiction treatment segment is anticipated to have the highest growth rate with respect to value.
Report Attributes | Report Details |
---|---|
Report Name | Substance Abuse Treatment Market |
Market Size in 2023 | USD 10.99 Billion |
Market Forecast in 2032 | USD 20.62 Billion |
Growth Rate | CAGR of 7.24% |
Number of Pages | 130 |
Key Companies Covered | Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma and Teva Pharmaceutical amongst others |
Segments Covered | By Abuse Type, By Treatment Type and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The geographical segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America led the market with regard to revenue owing to the presence of major players in the region and increasing awareness about substance abuse treatment.
Recently, different private and government agencies have launched substance abuse treatment campaigns. Europe is the second in terms of revenue attributing to the increase in investments in research and Development.
Key players within the global Substance Abuse Treatment market include
By Abuse Type Segment Analysis
By Treatment Type Segment Analysis
FrequentlyAsked Questions
Substance abuse treatment involves a range of therapies and interventions aimed at helping individuals overcome addiction to drugs or alcohol and achieve long-term recovery.
According to study, the Substance Abuse Treatment Market size was worth around USD 10.99 billion in 2023 and is predicted to grow to around USD 20.62 billion by 2032.
The CAGR value of Substance Abuse Treatment Market is expected to be around 7.24% during 2024-2032.
North America has been leading the Substance Abuse Treatment Market and is anticipated to continue on the dominant position in the years to come.
The Substance Abuse Treatment Market is led by players like Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma and Teva Pharmaceutical amongst others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed